<DOC>
	<DOC>NCT00059722</DOC>
	<brief_summary>The purpose of this study is to compare the efficacy of ZD6474 and ZD1839 in patients with NSCLC after Failure of Prior Platinum-based Chemotherapy.</brief_summary>
	<brief_title>This Study is to Compare the Efficacy of ZD6474 and ZD1839 in Subjects With NSCLC.</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
	<mesh_term>Gefitinib</mesh_term>
	<criteria>Failure of either firstline and/or secondline chemotherapy either of which was platinumbased (the prior regimen must have failed the subject because of toxicity or progression of tumor Prior histologic or cytologic confirmation of locally advanced or metastatic (IIIB/IV) NSCLC Subjects who have received secondline or subsequent chemotherapy Any evidence of clinically active interstitial lung disease (patients with chronic, stable, radiographic changes who are asymptomatic, need not be excluded)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>NSCLC</keyword>
	<keyword>locally advanced or metastatic</keyword>
	<keyword>second-line</keyword>
</DOC>